BioAegis Therapeutics Unveils Upcoming Clinical Study of
BioAegis announces global Phase 2 study of its inflammation regulator protein, gelsolin, for the treatment of Acute Respiratory Distress Syndrome (ARDS). ...
Source: globenewswire.com
Stay updated with breaking news from Multitasking Protein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioAegis announces global Phase 2 study of its inflammation regulator protein, gelsolin, for the treatment of Acute Respiratory Distress Syndrome (ARDS). ...
Partnership supports execution of a large phase 2 global study to evaluate efficacy and safety of recombinant human plasma gelsolin (rhu-pGSN) for...